Literature DB >> 20816278

Treatment options for parasomnias.

Hrayr Attarian1.   

Abstract

Parasomnias are undesirable physical or experiential events that occur in and around sleep. Treatments include reassurance in some cases, various forms of cognitive-behavioral therapy (CBT), and pharmacologic agents. Cognitive restructuring, imagery rehearsal, relaxation, hypnosis, desensitization, and anticipatory awakenings are some of the common CBT and nonpharmacologic interventions. Medications that are used belong to a wide variety of pharmacologic classes, such as alpha-blockers (prazosin), tricyclic antidepressants (imipramine and clomipramine), selective serotonin reuptake inhibitors, benzodiazepines (diazepam and clonazepam), anticonvulsants (topiramate and gabapentin), desmopressin acetate, and anticholinergic agents (oxybutynin and tolterodine). Data on efficacy are only available from randomized trials on CBT and prazosin for nightmares and on pharmacologic and alarm therapy for enuresis. No large-scale randomized trials are available to assess the efficacy of the other treatments, and most data come from anecdotal case reports, case series, or small open-label trials. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816278     DOI: 10.1016/j.ncl.2010.03.025

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  6 in total

Review 1.  Management of post-traumatic nightmares: a review of pharmacologic and nonpharmacologic treatments since 2010.

Authors:  Monica Escamilla; Mercedes LaVoy; Bret A Moore; Barry Krakow
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 2.  Parasomnias.

Authors:  John A Fleetham; Jonathan A E Fleming
Journal:  CMAJ       Date:  2014-05-05       Impact factor: 8.262

3.  Use of topiramate in pregnancy and risk of oral clefts.

Authors:  Andrea V Margulis; Allen A Mitchell; Suzanne M Gilboa; Martha M Werler; Murray A Mittleman; Robert J Glynn; Sonia Hernandez-Diaz
Journal:  Am J Obstet Gynecol       Date:  2012-07-16       Impact factor: 8.661

Review 4.  Therapeutic Symptomatic Strategies in the Parasomnias.

Authors:  Raffaele Manni; Gianpaolo Toscano; Michele Terzaghi
Journal:  Curr Treat Options Neurol       Date:  2018-06-05       Impact factor: 3.598

Review 5.  Behavioural and Cognitive-Behavioural Treatments of Parasomnias.

Authors:  Andrea Galbiati; Fabrizio Rinaldi; Enrico Giora; Luigi Ferini-Strambi; Sara Marelli
Journal:  Behav Neurol       Date:  2015-05-25       Impact factor: 3.342

6.  A case report of somnambulism associated with olanzapine.

Authors:  Farhad Faridhosseini; Azar Zamani
Journal:  Iran J Psychiatry Behav Sci       Date:  2012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.